129 related articles for article (PubMed ID: 26035715)
1. U0126 inhibits pancreatic cancer progression via the KRAS signaling pathway in a zebrafish xenotransplantation model.
Guo M; Wei H; Hu J; Sun S; Long J; Wang X
Oncol Rep; 2015 Aug; 34(2):699-706. PubMed ID: 26035715
[TBL] [Abstract][Full Text] [Related]
2. Signal therapy of human pancreatic cancer and NF1-deficient breast cancer xenograft in mice by a combination of PP1 and GL-2003, anti-PAK1 drugs (Tyr-kinase inhibitors).
Hirokawa Y; Levitzki A; Lessene G; Baell J; Xiao Y; Zhu H; Maruta H
Cancer Lett; 2007 Jan; 245(1-2):242-51. PubMed ID: 16540233
[TBL] [Abstract][Full Text] [Related]
3. Nicotine promotes initiation and progression of KRAS-induced pancreatic cancer via Gata6-dependent dedifferentiation of acinar cells in mice.
Hermann PC; Sancho P; Cañamero M; Martinelli P; Madriles F; Michl P; Gress T; de Pascual R; Gandia L; Guerra C; Barbacid M; Wagner M; Vieira CR; Aicher A; Real FX; Sainz B; Heeschen C
Gastroenterology; 2014 Nov; 147(5):1119-33.e4. PubMed ID: 25127677
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic effects of an anti-Myc drug on mouse pancreatic cancer.
Stellas D; Szabolcs M; Koul S; Li Z; Polyzos A; Anagnostopoulos C; Cournia Z; Tamvakopoulos C; Klinakis A; Efstratiadis A
J Natl Cancer Inst; 2014 Dec; 106(12):. PubMed ID: 25306215
[TBL] [Abstract][Full Text] [Related]
5. Farnesyltransferase inhibitor (L-744,832) restores TGF-beta type II receptor expression and enhances radiation sensitivity in K-ras mutant pancreatic cancer cell line MIA PaCa-2.
Alcock RA; Dey S; Chendil D; Inayat MS; Mohiuddin M; Hartman G; Chatfield LK; Gallicchio VS; Ahmed MM
Oncogene; 2002 Nov; 21(51):7883-90. PubMed ID: 12420225
[TBL] [Abstract][Full Text] [Related]
6. Pharmacologic inhibition of RAF-->MEK-->ERK signaling elicits pancreatic cancer cell cycle arrest through induced expression of p27Kip1.
Gysin S; Lee SH; Dean NM; McMahon M
Cancer Res; 2005 Jun; 65(11):4870-80. PubMed ID: 15930308
[TBL] [Abstract][Full Text] [Related]
7. Reactivation of BMP signaling by suboptimal concentrations of MEK inhibitor and FK506 reduces organ-specific breast cancer metastasis.
Ren J; Wang Y; Ware T; Iaria J; Ten Dijke P; Zhu HJ
Cancer Lett; 2020 Nov; 493():41-54. PubMed ID: 32768522
[TBL] [Abstract][Full Text] [Related]
8. Analysis of invasion-metastasis mechanism in pancreatic cancer: involvement of tight junction transmembrane protein occludin and MEK/ERK signal transduction pathway in cancer cell dissociation.
Tan X; Tamori Y; Egami H; Ishikawa S; Kurizaki T; Takai E; Hirota M; Ogawa M
Oncol Rep; 2004 May; 11(5):993-8. PubMed ID: 15069537
[TBL] [Abstract][Full Text] [Related]
9. Antibody-mediated delivery of anti-KRAS-siRNA in vivo overcomes therapy resistance in colon cancer.
Bäumer S; Bäumer N; Appel N; Terheyden L; Fremerey J; Schelhaas S; Wardelmann E; Buchholz F; Berdel WE; Müller-Tidow C
Clin Cancer Res; 2015 Mar; 21(6):1383-94. PubMed ID: 25589625
[TBL] [Abstract][Full Text] [Related]
10. Targeted therapy of human leukemia xenografts in immunodeficient zebrafish.
Somasagara RR; Huang X; Xu C; Haider J; Serody JS; Armistead PM; Leung T
Sci Rep; 2021 Mar; 11(1):5715. PubMed ID: 33707624
[TBL] [Abstract][Full Text] [Related]
11. The tumor suppressor rpl36 restrains KRAS(G12V)-induced pancreatic cancer.
Provost E; Bailey JM; Aldrugh S; Liu S; Iacobuzio-Donahue C; Leach SD
Zebrafish; 2014 Dec; 11(6):551-9. PubMed ID: 25380065
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of the nuclear factor-kappaB by lidamycin in association with inducing apoptosis in human pancreatic cancer cells and inhibiting xenograft growth.
Chen J; Ouyang ZG; Zhang SH; Zhen YS
Oncol Rep; 2007 Jun; 17(6):1445-51. PubMed ID: 17487403
[TBL] [Abstract][Full Text] [Related]
13. Nicotinamide prohibits proliferation and enhances chemosensitivity of pancreatic cancer cells through deregulating SIRT1 and Ras/Akt pathways.
Zhang JG; Zhao G; Qin Q; Wang B; Liu L; Liu Y; Deng SC; Tian K; Wang CY
Pancreatology; 2013; 13(2):140-6. PubMed ID: 23561972
[TBL] [Abstract][Full Text] [Related]
14. A novel zebrafish human tumor xenograft model validated for anti-cancer drug screening.
Jung DW; Oh ES; Park SH; Chang YT; Kim CH; Choi SY; Williams DR
Mol Biosyst; 2012 Jul; 8(7):1930-9. PubMed ID: 22569777
[TBL] [Abstract][Full Text] [Related]
15. Retinoic acid receptor antagonists inhibit miR-10a expression and block metastatic behavior of pancreatic cancer.
Weiss FU; Marques IJ; Woltering JM; Vlecken DH; Aghdassi A; Partecke LI; Heidecke CD; Lerch MM; Bagowski CP
Gastroenterology; 2009 Dec; 137(6):2136-45.e1-7. PubMed ID: 19747919
[TBL] [Abstract][Full Text] [Related]
16. Gene expression profiling and pathway analysis identify the integrin signaling pathway to be altered by IL-1β in human pancreatic cancer cells: role of JNK.
Verma G; Bhatia H; Datta M
Cancer Lett; 2012 Jul; 320(1):86-95. PubMed ID: 22313544
[TBL] [Abstract][Full Text] [Related]
17. Characterization of Kras-mediated pancreatic tumorigenesis in zebrafish.
Davison JM; Woo Park S; Rhee JM; Leach SD
Methods Enzymol; 2008; 438():391-417. PubMed ID: 18413263
[TBL] [Abstract][Full Text] [Related]
18. Expression of KRASG12V in Zebrafish Gills Induces Hyperplasia and CXCL8-Associated Inflammation.
Shive HR; West RR; Embree LJ; Sexton JM; Hickstein DD
Zebrafish; 2015 Jun; 12(3):221-9. PubMed ID: 25798815
[TBL] [Abstract][Full Text] [Related]
19. Stimulation of hepatocarcinogenesis by neutrophils upon induction of oncogenic kras expression in transgenic zebrafish.
Yan C; Huo X; Wang S; Feng Y; Gong Z
J Hepatol; 2015 Aug; 63(2):420-8. PubMed ID: 25828472
[TBL] [Abstract][Full Text] [Related]
20. Zebrafish as a model for human osteosarcoma.
Mohseny AB; Hogendoorn PC
Adv Exp Med Biol; 2014; 804():221-36. PubMed ID: 24924177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
